comparemela.com
Home
Live Updates
FDA Accepts Isatuximab for Priority Review for Treatment of
FDA Accepts Isatuximab for Priority Review for Treatment of
FDA Accepts Isatuximab for Priority Review for Treatment of Transplant-Ineligible Multiple Myeloma
Isatuximab is used in combination with bortezomib, lenalidomide, and dexamethanose.
Related Keywords
United States ,
Dietmar Berger ,
Amgen Inc ,
Zydus Pharmaceuticals Inc ,
Janssen Pharmaceutical Companies ,